ATGen Co., Ltd. logo

ATGen Co., Ltd.

2 Marks
Other
First Filed:Jun 4, 2014Latest Filed:Nov 12, 2018Address:ATGen, Institut Pasteur Korea 2F, Gyeonggi-do 463-400, KR

Portfolio Overview

Previous
2

Top Classes

Class 40
Material Treatment
2(100%)

TTAB Proceedings

Total Proceedings
3
As Plaintiff
0(0%)
As Defendant
3(100%)

Top Firms

Loading...

Trademark Portfolio

4 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
ATGENGLOBAL
ATGENGLOBAL
Trademark
Word
ABANDONED
Owner:
Serial:88191008
Filed:Nov 12, 2018
Classes:40
ATGEN
ATGEN
Trademark
Combined
ABANDONED
Owner:
Serial:86300715
Filed:Jun 4, 2014
Classes:40
NK VUE
NK VUE
Trademark
Word
Previous
REGISTERED
Owner:
Serial:86300720
Filed:Jun 4, 2014
Classes:1, 5
Registration:4993881
Registered:Jul 5, 2016
Goods & Services
diagnostic kits for medical diagnostic use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic activators in the nature of proteins for use in diagnostic kits for disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic preparations for medical diagnostic use; diagnostic reagents for medical diagnostic use; NK cell activation testing kits containing peptide substrates used in analyzing and detecting certain toxins for clinical, research or medical laboratory use; diagnostic kits for clinical laboratory use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for medical laboratory use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for medical research use, namely, kits consisting primarily of (monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for clinical research use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic preparations for clinical laboratory use and medical laboratory use; diagnostic preparations for clinical research use other than for medical use; diagnostic reagents for clinical laboratory use, medical laboratory use, medical research use and clinical research use; "NK"
PROMOCA
PROMOCA
Trademark
Word
Previous
CANCELLED
Owner:
Serial:86300729
Filed:Jun 4, 2014
Classes:1
Registration:5098113
Registered:Dec 13, 2016